How many cuts in PC?

[anonymous]

Seems like they are holding on to Symbi/Crestor detailing to the bitter end

 

[anonymous]

The recent cuts are really just fine tuning for the hammer to fall. 1.1 BILLION in Adminstrative cost savings that were detailed in April is directly tied to sales force reductions in the US. Based on other large pharma restructuring, we can expect anywhere from a 25%-40% total sales force restructuring. Do not listen to the posts about tenured reps or those with low ratings being targeted. The layoffs will be across the board, severances will be in line with policy and the shareholders will expect to a increase in bottom line value in line with growth expectations with a stock price target of $34.31 per share ADR.

 

[anonymous]

The recent cuts are really just fine tuning for the hammer to fall. 1.1 BILLION in Adminstrative cost savings that were detailed in April is directly tied to sales force reductions in the US. Based on other large pharma restructuring, we can expect anywhere from a 25%-40% total sales force restructuring. Do not listen to the posts about tenured reps or those with low ratings being targeted. The layoffs will be across the board, severances will be in line with policy and the shareholders will expect to a increase in bottom line value in line with growth expectations with a stock price target of $34.31 per share ADR.

I have been telling you guys for months that this is being done in 3 phases and this is only phase 1. It is intended to maximize sales before going generic and to avoid panic in the sales force.
Every phase there are people who will breath a sigh of relief and things return to normal until the next phase of cuts kicks in. There will not be an opportunity to self identify.